✦ LIBER ✦

Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

✍ Scribed by Dhillon, Sohita

Book ID: 121632156
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 503 KB
Volume: 27
Category: Article
ISSN: 1173-8804
DOI: 10.1007/s40259-013-0043-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beyond tertiary cytoreduction in patient

Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer

✍ K.K. Shih; D.S. Chi; R.R. Barakat; M.M. Leitao Jr. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Outcome differences in patients with adv

Outcome differences in patients with advanced epithelial ovarian, primary peritoneal and fallopian tube cancers treated with and without bevacizumab

✍ Randall, L.; Burger, R.; Nguyen, H.; Kong, G.; Bookman, M.; Fleming, G.; Monk, B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Tertiary cytoreduction in patients with

Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: An updated series

✍ K.K. Shih; D.S. Chi; R.R. Barakat; M.M. Leitao Jr. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Phase II study of bevacizumab and pemetr

Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer

✍ Hagemann, Andrea R.; Novetsky, Akiva P.; Zighelboim, Israel; Gao, Feng; Massad, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 264 KB

A phase II trial of weekly docetaxel in

A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

OCEANS: A Randomized, Double-Blind, Plac

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

✍ Aghajanian, C.; Blank, S. V.; Goff, B. A.; Judson, P. L.; Teneriello, M. G.; Hus 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 348 KB